Herpes simplex virus Us3(-) mutant as oncolytic strategy and synergizes with phosphatidylinositol 3-kinase-Akt-targeting molecular therapeutics
- Ta Chiang Liu
- , Hiroaki Wakimoto
- , Robert L. Martuza
- , Samuel D. Rabkin
- Roy and Diana Vagelos Division of Biology & Biomedical Sciences (DBBS)
- Institute of Clinical and Translational Sciences (ICTS)
- Siteman Cancer Center
- Division of Anatomic and Molecular Pathology (AMP)
- DBBS - Developmental, Regenerative and Stem Cell Biology
- DBBS - Immunology
- DBBS - Molecular Microbiology and Microbial Pathogenesis
- Bursky Center for Human Immunology and Immunotherapy
Research output: Contribution to journal › Article › peer-review
31
Link opens in a new tab
Scopus
citations